butyric acid has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cowley, EA; Denovan-Wright, EM; Linsdell, P; Roy, J | 1 |
| Hearne, JL; Kiessu, E; Martin-Caraballo, M; Puplampu-Dove, YA; Weaver, EM; Zamora, FJ | 1 |
2 other study(ies) available for butyric acid and thapsigargin
| Article | Year |
|---|---|
Exposure to sodium butyrate leads to functional downregulation of calcium-activated potassium channels in human airway epithelial cells.
Topics: Benzimidazoles; Butyric Acid; Calcium; Calcium Channel Agonists; Cell Line; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Lung; Thapsigargin | 2006 |
Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Topics: Butyric Acid; Calcium Channels, T-Type; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Histone Deacetylase Inhibitors; Humans; Male; Paclitaxel; Prostatic Neoplasms; Thapsigargin | 2015 |